OGN vs. ABT
Compare and contrast key facts about Organon & Co. (OGN) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OGN or ABT.
Correlation
The correlation between OGN and ABT is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
OGN vs. ABT - Performance Comparison
Loading data...
Key characteristics
OGN:
-1.08
ABT:
1.49
OGN:
-1.59
ABT:
2.23
OGN:
0.78
ABT:
1.28
OGN:
-0.73
ABT:
1.26
OGN:
-1.93
ABT:
7.58
OGN:
28.66%
ABT:
4.25%
OGN:
51.56%
ABT:
21.04%
OGN:
-75.77%
ABT:
-45.66%
OGN:
-72.75%
ABT:
-3.42%
Fundamentals
OGN:
$2.28B
ABT:
$232.01B
OGN:
$3.14
ABT:
$7.99
OGN:
2.79
ABT:
16.69
OGN:
0.36
ABT:
5.48
OGN:
4.21
ABT:
4.75
OGN:
$6.29B
ABT:
$42.34B
OGN:
$3.60B
ABT:
$23.67B
OGN:
$1.50B
ABT:
$11.20B
Returns By Period
In the year-to-date period, OGN achieves a -38.15% return, which is significantly lower than ABT's 20.36% return.
OGN
-38.15%
-16.26%
-38.61%
-55.75%
N/A
N/A
ABT
20.36%
3.93%
17.46%
31.12%
10.41%
12.80%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
OGN vs. ABT — Risk-Adjusted Performance Rank
OGN
ABT
OGN vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Organon & Co. (OGN) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
OGN vs. ABT - Dividend Comparison
OGN's dividend yield for the trailing twelve months is around 9.51%, more than ABT's 1.69% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OGN Organon & Co. | 9.51% | 7.51% | 7.77% | 4.01% | 1.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABT Abbott Laboratories | 1.69% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
OGN vs. ABT - Drawdown Comparison
The maximum OGN drawdown since its inception was -75.77%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for OGN and ABT. For additional features, visit the drawdowns tool.
Loading data...
Volatility
OGN vs. ABT - Volatility Comparison
Organon & Co. (OGN) has a higher volatility of 37.83% compared to Abbott Laboratories (ABT) at 5.61%. This indicates that OGN's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
OGN vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Organon & Co. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
OGN vs. ABT - Profitability Comparison
OGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Organon & Co. reported a gross profit of 841.00M and revenue of 1.51B. Therefore, the gross margin over that period was 55.6%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
OGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Organon & Co. reported an operating income of 325.00M and revenue of 1.51B, resulting in an operating margin of 21.5%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
OGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Organon & Co. reported a net income of 87.00M and revenue of 1.51B, resulting in a net margin of 5.8%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.